FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 332:1235-1237 May 4, 1995 Number 18 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Bjoro, K.

To the Editor: The article by Bjøro et al.¹ and the accompanying editorial by Schiff (Dec. 15 issue)² focus on the potential risks of transmission of hepatitis C by intravenous immune globulin. In this follow-up study of Norwegian patients who received contaminated lots of intravenous immune globulin between 1982 and 1986, the patients with hypogammaglobulinemia had a high risk of hepatitis C infection and a severe and rapidly progressive course, with poor responses to recombinant interferon alfa-2b. Bjøro et al.¹ present an unbalanced viewpoint that is likely to alarm physicians and patients with other disorders who may benefit from this . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.